Kardia-3

Enrolling, Hypertension
The purpose of this study is to evaluate the effect of zilebesiran as add-on therapy in patients with high cardiovascular risk and…

MUIR-3

Enrolling, High Triglyceride
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia…

Redefine-3

Enrolling, Weight Loss
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with…

Shasta-4

Enrolling, High Triglyceride
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe…

BalanceD-HF

Enrolling, Heart Failure
The purpose of this study is to investigate the effect of balcinrenone/dapagliflozin compared with dapagliflozin, on the risk of CV death…

Triumph

Enrolling, Weight Loss
The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and…

Tandem

In Follow Up, Cholesterol
The study is a placebo-controlled, double-blind, randomized, phase 3 study in participants with heterozygous familial hypercholesterolemia…

Tharros

Enrolling, COPD
THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a…

Acclaim

Enrolling, Lipoprotein (a)
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a…

V-Prevent

In Follow Up, Cholesterol
The purpose of this study is to evaluate inclisiran sodium 300 mg s.c. (equivalent to 284 mg inclisiran) compared to placebo on reducing the…

Synchronize

In Follow Up
The purpose of this study is to find out whether people with overweight or obesity who take a medicine called survodutide (BI 456906) are…

Hermes

Enrolling, Heart Failure
This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will…
Capital Area Research LLC © Copyright 2024 All rights reserved.
875 Popular Church Rd. Suite 330 Camp Hill, PA - 717.963.8389